v3.25.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
Acquired in-process research and development, related party $ 0 $ 51,659
Research and development expense 46,713 14,336
General and administrative 21,170 16,025
Total operating expenses 67,883 82,020
Total loss from operations (67,883) (82,020)
Other income (expense):    
Foreign currency loss (291) (9)
Interest income 8,323 8,132
Total other income (expense) 8,032 8,123
Net loss $ (59,851) $ (73,897)
Net loss per share, diluted $ (0.88) $ (1.53)
Net loss per share, basic $ (0.88) $ (1.53)
Weighted-average number of shares used to compute net loss per share, diluted 67,812,145 48,163,301
Weighted-average number of shares used to compute net loss per share, basic 67,812,145 48,163,301
Comprehensive loss:    
Net Income (Loss) $ (59,851) $ (73,897)
Other comprehensive income (loss):    
Unrealized gain on marketable securities 412 25
Comprehensive loss $ (59,439) $ (73,872)